Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM5M1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,040
Award facts
- Contract value 100% obligated
- $2,039.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,039.70 to AmerisourceBergen Drug Corp for HEPLISAV-B 20 mcg/0.5 mL syringes on December 3, 2025, with completion scheduled for December 4, 2025. HEPLISAV-B is a recombinant hepatitis B vaccine indicated for adults aged 18 years and older. This delivery order was competitively awarded without set-aside designation under a firm fixed price contract structure, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania.
This award represents a task order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical devices to support military and veteran healthcare systems. The company's extensive contract portfolio with DLA demonstrates its established capability to meet federal procurement requirements for vaccines and pharmaceutical commodities across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM5M1?
SPE2DR26FM5M1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FM5M1 worth?
The government has obligated $2,040 on SPE2DR26FM5M1.
Is contract SPE2DR26FM5M1 an order under another contract?
Yes. SPE2DR26FM5M1 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM5M1 competed?
The extent of competition for SPE2DR26FM5M1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award